
EWTX Technical Analysis Summary (NASDAQ)
Analyze EWTX on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerEWTX Technical Analysis Summary (NASDAQ)
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Edgewise Therapeutics, Inc. on the NASDAQ is awaiting a decisive move. Overall, Edgewise Therapeutics, Inc. remains neutral, with indicators showing mixed momentum.
RSI (14): 60.04
Stochastic %K: 46.58
Williams %R: -10.53
Rate of Change (ROC): 8.95
Takeaway:Edgewise Therapeutics, Inc. shows steady upward momentum, supported by improving signals.
MACD: 0.47
ADX: 12.95
ATR (14): 2.75
CCI (14): 247.32
Takeaway:Edgewise Therapeutics, Inc. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Edgewise Therapeutics, Inc. trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Edgewise Therapeutics, Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:EWTX shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
Overall Recommendation:Technical indicators for Edgewise Therapeutics, Inc. are mixed, suggesting a Hold or wait-and-see approach.